Endodermal sinus tumor: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(121 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
{{CMG}} {{AE}} {{MD}}; {{Ammu}}
{{CMG}} {{AE}} {{G.D.}}; {{MD}}; {{SM}}; {{Ammu}}


{{SK}} EST
'''For patient information, click [[Endodermal sinus tumor (patient information)|here]]'''
{{SK}} Endodermal sinus tumor(EST), yolk sac tumor.
==Overview==
==Overview==
Endodermal sinus tumor was first discovered by Dr. Gunner Telium, a Danish pathologist, in 1959. The hypermethylation of the RUNX3 [[gene]] [[promoter]] and [[overexpression]] of GATA-4, a [[transcription factor]] has been associated with the [[development]] of endodermal sinus tumor. Endodermal sinus tumor is a rare type of [[malignant]] [[ovarian tumor]] that occurs in the second decade of life. On [[gross]] [[pathology]], a [[solid]] gray-white with gelatinous, myxoid, or mucoid appearance, [[necrosis]], [[cystic]] changes, and [[hemorrhage]] are characteristic findings of endodermal sinus tumor. On [[microscopic]] [[histopathological]] analysis, Schiller-Duval bodies is a characteristic finding of endodermal sinus tumor. Endodermal sinus tumor must be differentiated from other [[diseases]] that cause [[Pelvic|pelvic mass]], such as [[Stein-Leventhal syndrome]], and [[seminoma]]. In 2015, the [[incidence]] of endodermal sinus tumor is estimated to less than 1/100,000 case per year in U.S. Endodermal sinus tumor may be classified according to [[histology]] groups.The [[diagnosis]] of endodermal sinus tumor is made based on the [[imaging]] (U/S and MRI) and [[alpha fetoprotein]] ([[AFP]]) [[tumor marker]] greater than 100 ng/ml. Endodermal sinus tumor have a [[bimodal distribution]] more commonly observed among [[Young adult|young]] and [[adult]] [[population]]. The [[symptoms]] of endodermal sinus tumor include the followings: [[abdominal distention]], acute/sub acute [[abdominal pain]]. Endodermal sinus tumor is treated with [[surgery]] depending on the [[tumor]] [[marker]] and [[imaging]] as well as [[fertility]] desired.The [[medical]] [[therapy]] for endodermal sinus tumor is [[chemotherapy]] such as [[bleomycin]], [[etoposide]], and [[cisplatin]] for 3 to 4 cycles for 21 days.
==Historical Perspective==
==Historical Perspective==
*[Disease name] was first discovered by [scientist name], a
*Endodermal sinus tumor was first discovered by Dr. Gunner Telium, a Danish [[pathologist]] in 1959.<ref>{{cite book | last = Carmen | first = Marcela | title = Uncommon gynecologic cancers | publisher = Wiley Blackwell | location = Chichester, England | year = 2015 | isbn = 978-1-118-65535-1 }}</ref><ref name="pmid18767035">{{cite journal| author=Shah JP, Kumar S, Bryant CS, Ali-Fehmi R, Malone JM, Deppe G et al.| title=A population-based analysis of 788 cases of yolk sac tumors: A comparison of males and females. | journal=Int J Cancer | year= 2008 | volume= 123 | issue= 11 | pages= 2671-5 | pmid=18767035 | doi=10.1002/ijc.23792 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18767035  }}</ref>
[nationality + occupation], in [year] during/following [event].
 
*In [year], [gene] mutations were first identified in the pathogenesis
of [disease name].
*In [year], the first [discovery] was developed by [scientist] to
treat/diagnose [disease name].
==Classification==
==Classification==
*[Disease name] may be classified according to [classification method]
*Endodermal sinus tumor may be classified according to [[histology]] into 10 groups:<ref>{{cite book | last = Weidner | first = Noel | title = Modern surgical pathology | publisher = Saunders/Elsevier | location = Philadelphia, PA | year = 2009 | isbn = 978-1-4160-3966-2 }}</ref>
into [number] subtypes/groups:
 
:*[group1]
:*[[Reticular]]
:*[group2]
:*Endodermal sinus-like
:*[group3]
:*Microcystic
*Other variants of [disease name] include [disease subtype 1],
:*[[Papillary]]
[disease subtype 2], and [disease subtype 3].
:*[[Solid]]
:*[[Glandular]]
:*[[Alveolar]]
:*[[Vesicular|Polyvesicular]] vitelline
:*Enteric
:*Hepatoid
==Pathophysiology==
==Pathophysiology==
*The pathogenesis of [disease name] is characterized by [feature1],
*The hypermethylation of the RUNX3 gene promoter and [[overexpression]] of GATA-4, a [[transcription factor]] has been associated with the development of endodermal sinus tumor.<ref name="pmid12875960">{{cite journal| author=Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T| title=Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. | journal=Am J Pathol | year= 2003 | volume= 163 | issue= 2 | pages= 387-91 | pmid=12875960 | doi=10.1016/S0002-9440(10)63668-1 | pmc=1868235 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12875960  }} </ref>
[feature2], and [feature3].
*[[Ovarian]] endodermal sinus tumor may be result of differentiation of primitive [[malignant]] [[germ cell]] components of vitelline structures.<ref>{{cite book | last = Crum | first = Christopher | title = Diagnostic gynecologic and obstetric pathology | publisher = Elsevier, Inc | location = Philadelphia, PA | year = 2018 | isbn = 978-0-323-44732-4 }}</ref>
*The [gene name] gene/Mutation in [gene name] has been associated with
*On gross [[pathology]], encaptulated, firm, smooth, round, globular, solid gray-white with a gelatinous, myxoid, or mucoid appearance, [[necrosis]], [[cystic]] changes, and [[hemorrhage]] are characteristic findings of endodermal sinus tumor.<ref>{{cite book | last = Carmen | first = Marcela | title = Uncommon gynecologic cancers | publisher = Wiley Blackwell | location = Chichester, England | year = 2015 | isbn = 978-1-118-65535-1 }}</ref>
the development of [disease name], involving the [molecular pathway]
*On [[microscopic]] [[histopathological]] analysis, Schiller-Duval bodies (invaginated papillary structures with central vessel) is a characteristic finding of endodermal sinus tumor. The [[tumors]] are composed of irregular space lined by flattened to cuboidal cells and recticular stroma<ref>{{cite book | last = Carmen | first = Marcela | title = Uncommon gynecologic cancers | publisher = Wiley Blackwell | location = Chichester, England | year = 2015 | isbn = 978-1-118-65535-1 }}</ref>.<ref name="pmid63318">{{cite journal| author=Kurman RJ, Norris HJ| title=Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. | journal=Cancer | year= 1976 | volume= 38 | issue= 6 | pages= 2404-19 | pmid=63318 | doi=10.1002/1097-0142(197612)38:6<2404::aid-cncr2820380629>3.0.co;2-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=63318  }} </ref>
pathway.
*On gross pathology, [feature1], [feature2], and [feature3] are
characteristic findings of [disease name].
*On microscopic histopathological analysis, [feature1], [feature2],
and [feature3] are characteristic findings of [disease name].
==Causes==
==Causes==
* [Disease name] may be caused by either [cause1], [cause2], or
* There are no established [[causes]] for endodermal sinus tumor.<ref name="Makris2017">{{cite journal|last1=Makris|first1=Georgios-Marios|title=Giving Birth After Fertility Sparing Treatment for a Yolk Sac Tumour: Case Report|journal=JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH|year=2017|issn=2249782X|doi=10.7860/JCDR/2017/25820.10524}}</ref>
[cause3].
 
* [Disease name] is caused by a mutation in the [gene1], [gene2], or
==Differentiating Endodermal sinus tumor from Other Diseases==
[gene3] gene[s].
Endodermal sinus tumor must be differentiated from other [[diseases]] that cause [[pelvic mass]], [[abdominal pain]] and [[abdominal distention]] such as:<ref name="sba">Shaaban AM, Rezvani M, Elsayes KM, et al. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. Radiographics. 2014;34(3):777-801.http://pubs.rsna.org/doi/pdf/10.1148/rg.343130067</ref><ref name="ajk">Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics. 2002;22(6):1305-25.http://www.ncbi.nlm.nih.gov/pubmed/12432104</ref>
* There are no established causes for [disease name].
 
==Differentiating [disease name] from other Diseases==
* Stein-Leventhal [[syndrome]]
*[Disease name] must be differentiated from other diseases that cause
 
[clinical feature 1], [clinical feature 2], and [clinical feature 3],
* [[Ovary]] [[teratoma]]
such as:
 
:*[Differential dx1]
* Tubal [[pregnancy]]
:*[Differential dx2]
 
:*[Differential dx3]
*[[Ovary|Ovary adenocarcinoma]]
 
*[[Tubo-ovarian abscess|Tubo-ovarian]] [[abscess]]
*[[Seminoma]]
* For more information on endodermal sinus tumor differential diagnosis, [[Testicular cancer differential diagnosis|click here]].
* Also, you can find more information by [[Ovarian germ cell tumor differential diagnosis|clicking here]].
 
==Epidemiology and Demographics==
==Epidemiology and Demographics==
* The prevalence of [disease name] is approximately [number or range]
*In 2015, the [[incidence]] of endodermal sinus tumor is estimated to less than 1/100,000 case per [[year]] in U.S.<ref name="pmid1111694">{{cite journal| author=Young JL, Miller RW| title=Incidence of malignant tumors in U. S. children. | journal=J Pediatr | year= 1975 | volume= 86 | issue= 2 | pages= 254-8 | pmid=1111694 | doi=10.1016/s0022-3476(75)80484-7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1111694  }} </ref>
per 100,000 individuals worldwide.
* In [year], the incidence of [disease name] was estimated to be
[number or range] cases per 100,000 individuals in [location].
===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Endodermal sinus tumor have a [[bimodal distribution]] more commonly observed among [[Young adult|young]] and [[Adult|adult population]]<ref name="pmid18767035">{{cite journal| author=Shah JP, Kumar S, Bryant CS, Ali-Fehmi R, Malone JM, Deppe G et al.| title=A population-based analysis of 788 cases of yolk sac tumors: A comparison of males and females. | journal=Int J Cancer | year= 2008 | volume= 123 | issue= 11 | pages= 2671-5 | pmid=18767035 | doi=10.1002/ijc.23792 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18767035  }} </ref>
*[Disease name] is more commonly observed among patients aged [age
* Pure yolk sac tumor (endodermal sinus tumor) affects mostly [[children]] of less 2 years old.<ref name="pmid8127257">{{cite journal| author=Coppes MJ, Rackley R, Kay R| title=Primary testicular and paratesticular tumors of childhood. | journal=Med Pediatr Oncol | year= 1994 | volume= 22 | issue= 5 | pages= 329-40 | pmid=8127257 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8127257  }} </ref>
range] years old.
*[Disease name] is more commonly observed among [elderly
patients/young patients/children].
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Endodermal sinus tumor affects [[men]] and women equally.<ref name="urlEndodermal Sinus Tumor - St. Jude Children’s Research Hospital">{{cite web |url=https://www.stjude.org/disease/endodermal-sinus-tumor.html |title=Endodermal Sinus Tumor - St. Jude Children’s Research Hospital |format= |work= |accessdate=}}</ref>
*[Gender 1] are more commonly affected with [disease name] than
 
[gender 2].
* The [gender 1] to [Gender 2] ratio is approximately [number > 1] to
1.
===Race===
===Race===
*There is no racial predilection for [disease name].
*There is no [[racial]] predilection for endodermal sinus tumor.
*[Disease name] usually affects individuals of the [race 1] race.
*[Race 2] individuals are less likely to develop [disease name].
==Risk Factors==
*Common risk factors in the development of [disease name] are [risk
factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
== Natural History, Complications and Prognosis==
== Natural History, Complications and Prognosis==
*The majority of patients with [disease name] remain asymptomatic for
*Endodermal sinus tumor has a poor [[prognosis]] in [[adult]].<ref name="pmid12432104">{{cite journal| author=Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST| title=CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. | journal=Radiographics | year= 2002 | volume= 22 | issue= 6 | pages= 1305-25 | pmid=12432104 | doi=10.1148/rg.226025033 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12432104  }} </ref><ref name="pmid18063508">{{cite journal| author=Hung JH, Shen SH, Hung J, Lai CR| title=Ultrasound and magnetic resonance images of endodermal sinus tumor. | journal=J Chin Med Assoc | year= 2007 | volume= 70 | issue= 11 | pages= 514-8 | pmid=18063508 | doi=10.1016/S1726-4901(08)70052-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18063508  }} </ref>
[duration/years].
*Endodermal sinus tumor has a favorable [[prognosis]] in [[children]].<ref name="pmid12875960">{{cite journal| author=Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T| title=Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. | journal=Am J Pathol | year= 2003 | volume= 163 | issue= 2 | pages= 387-91 | pmid=12875960 | doi=10.1016/S0002-9440(10)63668-1 | pmc=1868235 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12875960  }} </ref>
*Early clinical features include [manifestation 1], [manifestation 2],
*Endodermal sinus tumor is the most common [[malignant germ cell tumor]] in [[children]].<ref name="pmid12432104">{{cite journal| author=Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST| title=CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. | journal=Radiographics | year= 2002 | volume= 22 | issue= 6 | pages= 1305-25 | pmid=12432104 | doi=10.1148/rg.226025033 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12432104  }} </ref><ref name="urlDefinition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute">{{cite web |url=https://www.cancer.gov/publications/dictionaries/cancer-terms/def/791307 |title=Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute |format= |work= |accessdate=}}</ref>
and [manifestation 3].
*If left untreated, endodermal sinus tumor quickly [[Metastasize|metastasizes]] in other parts of the [[body]] such as the [[brain]].<ref name="urlDefinition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute">{{cite web |url=https://www.cancer.gov/publications/dictionaries/cancer-terms/def/791307 |title=Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute |format= |work= |accessdate=}}</ref>
*If left untreated, [#%] of patients with [disease name] may progress
*Endodermal sinus tumor can be found in the [[ovaries]] or [[testicles]] including the [[chest]], [[abdomen]], and the [[brain]].<ref name="urlDefinition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute">{{cite web |url=https://www.cancer.gov/publications/dictionaries/cancer-terms/def/791307 |title=Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute |format= |work= |accessdate=}}</ref>
to develop [manifestation 1], [manifestation 2], and [manifestation
*Ovarian endodermal sinus tumor [[Metastasize|metastasizes]] quiclky into the intraabdominal area compared to [[testicular]] endodermal sinus tumor.<ref>{{cite book | last = Saia | first = Philip | title = Clinical gynecologic oncology | publisher = Elsevier | location = Philadelphia, PA | year = 2018 | isbn = 978-0-323-40067-1 }} </ref>
3].
*Common complications of [disease name] include [complication 1],
[complication 2], and [complication 3].
*Prognosis is generally [excellent/good/poor], and the [1/5/10year
mortality/survival rate] of patients with [disease name] is
approximately [#%].
== Diagnosis ==
== Diagnosis ==
===Diagnostic Criteria===
=== Diagnostic criteria ===
*The diagnosis of [disease name] is made when at least [number] of the
*The [[diagnosis]] of endodermal sinus tumor is made based on the imaging and [[alpha fetoprotein]] ([[AFP]]) [[tumor]] [[marker]] greater than 100 ng/ml.<ref name="pmid6155988">{{cite journal| author=Talerman A, Haije WG, Baggerman L| title=Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP. | journal=Cancer | year= 1980 | volume= 46 | issue= 2 | pages= 380-5 | pmid=6155988 | doi=10.1002/1097-0142(19800715)46:2<380::aid-cncr2820460228>3.0.co;2-u | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6155988  }} </ref><ref>{{cite book | last = Saia | first = Philip | title = Clinical gynecologic oncology | publisher = Elsevier | location = Philadelphia, PA | year = 2018 | isbn = 978-0-323-40067-1 }} </ref>
following [number] diagnostic criteria are met:
:*[criterion 1]
:*[criterion 2]
:*[criterion 3]
:*[criterion 4]
=== Symptoms ===
=== Symptoms ===
*[Disease name] is usually asymptomatic.
*Endodermal sinus tumor is usually [[asymptomatic]].<ref name="ChenYip2019">{{cite journal|last1=Chen|first1=Li Hsun|last2=Yip|first2=Kui-Chuen|last3=Wu|first3=Hsing-Ju|last4=Yong|first4=Su-Boon|title=Yolk Sac Tumor in an Eight-Year-Old Girl: A Case Report and Literature Review|journal=Frontiers in Pediatrics|volume=7|year=2019|issn=2296-2360|doi=10.3389/fped.2019.00169}}</ref>
*Symptoms of [disease name] may include the following:
*Most [[children]] and [[young adults]] with endodermal sinus tumor have stage I.<ref>{{cite book | last = Weidner | first = Noel | title = Modern surgical pathology | publisher = Saunders/Elsevier | location = Philadelphia, PA | year = 2009 | isbn = 978-1-4160-3966-2 }}</ref>
:*[symptom 1]
*[[Symptoms]] of endodermal sinus tumor may include the following:<ref name="www">{{cite book | last = Hoffman | first = Barbara | title = Williams gynecology | publisher = McGraw-Hill Medical | location = New York | year = 2012 | isbn = 9780071716727 }}</ref> <ref name="pmid6185892">{{cite journal| author=Gershenson DM, Del Junco G, Herson J, Rutledge FN| title=Endodermal sinus tumor of the ovary: the M. D. Anderson experience. | journal=Obstet Gynecol | year= 1983 | volume= 61 | issue= 2 | pages= 194-202 | pmid=6185892 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6185892  }} </ref>
:*[symptom 2]
 
:*[symptom 3]
:*[[Abdominal distention]]
:*[symptom 4]
:*[[Acute]]/subacute [[abdominal pain]]
:*[symptom 5]
:*[symptom 6]
=== Physical Examination ===
=== Physical Examination ===
*Patients with [disease name] usually appear [general appearance].
*[[Patient|Patients]] with endodermal sinus tumor usually appear normal.
*Physical examination may be remarkable for:
*[[Physical examination]] may be remarkable for:<ref name="abc">{{cite book | last = Hoffman | first = Barbara | title = Williams gynecology | publisher = McGraw-Hill Medical | location = New York | year = 2012 | isbn = 9780071716727 }}</ref>
:*[finding 1]
 
:*[finding 2]
:*[[Abdominal distention]]
:*[finding 3]
:*[[Abdominal]] [[tenderness]]
:*[finding 4]
:*[[Adnexal]] [[mass]]
:*[finding 5]
:*[[Testicular mass]]
:*[finding 6]
 
=== Laboratory Findings ===
=== Laboratory Findings ===
*There are no specific laboratory findings associated with [disease
*An elevated concentration of [[serum]] [[alpha fetoprotein]] is a [[diagnostic]] of endodermal sinus tumor.<ref name="pmid6155988">{{cite journal| author=Talerman A, Haije WG, Baggerman L| title=Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP. | journal=Cancer | year= 1980 | volume= 46 | issue= 2 | pages= 380-5 | pmid=6155988 | doi=10.1002/1097-0142(19800715)46:2<380::aid-cncr2820460228>3.0.co;2-u | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6155988  }} </ref>
name].
*[[SALL4]] (sal-like [[protein]] 4) is [[positive]] in endodermal sinus tumor.<ref>{{cite book | last = Crum | first = Christopher | title = Diagnostic gynecologic and obstetric pathology | publisher = Elsevier, Inc | location = Philadelphia, PA | year = 2018 | isbn = 978-0-323-44732-4 }} </ref>
*A [positive/negative] [test name] is diagnostic of [disease name].
*[[Alpha-fetoprotein|AFP]] is very important for [[diagnosis]], [[disease]] monitoring and early [[metastasis]].<ref name="pmid6155988">{{cite journal| author=Talerman A, Haije WG, Baggerman L| title=Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP. | journal=Cancer | year= 1980 | volume= 46 | issue= 2 | pages= 380-5 | pmid=6155988 | doi=10.1002/1097-0142(19800715)46:2<380::aid-cncr2820460228>3.0.co;2-u | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6155988  }} </ref>
*An [elevated/reduced] concentration of
[serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease
name].
*Other laboratory findings consistent with the diagnosis of [disease
name] include [abnormal test 1], [abnormal test 2], and [abnormal test
3].
===Imaging Findings===
===Imaging Findings===
*There are no [imaging study] findings associated with [disease name].
*On [[MRI]], endodermal sinus tumor is characterized by areas of [[haemorrhage]] and [[necrosis]].<ref name="pmid18063508">{{cite journal| author=Hung JH, Shen SH, Hung J, Lai CR| title=Ultrasound and magnetic resonance images of endodermal sinus tumor. | journal=J Chin Med Assoc | year= 2007 | volume= 70 | issue= 11 | pages= 514-8 | pmid=18063508 | doi=10.1016/S1726-4901(08)70052-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18063508  }} </ref>
*[Imaging study 1] is the imaging modality of choice for [disease
*[[Ultrasound]] shows [[solid]] and [[cystic]] [[mass]].<ref name="pmid18063508">{{cite journal| author=Hung JH, Shen SH, Hung J, Lai CR| title=Ultrasound and magnetic resonance images of endodermal sinus tumor. | journal=J Chin Med Assoc | year= 2007 | volume= 70 | issue= 11 | pages= 514-8 | pmid=18063508 | doi=10.1016/S1726-4901(08)70052-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18063508  }} </ref>
name].
 
*On [imaging study 1], [disease name] is characterized by [finding 1],
[finding 2], and [finding 3].
*[Imaging study 2] may demonstrate [finding 1], [finding 2], and
[finding 3].
=== Other Diagnostic Studies ===
=== Other Diagnostic Studies ===
*[Disease name] may also be diagnosed using [diagnostic study name].
*Endodermal sinus tumor may also be [[Diagnosis|diagnosed]] using [[biopsy]] and [[measurement]] of  GATA-4, a [[transcription factor]].<ref name="pmid10595911">{{cite journal| author=Siltanen S, Anttonen M, Heikkilä P, Narita N, Laitinen M, Ritvos O et al.| title=Transcription factor GATA-4 is expressed in pediatric yolk sac tumors. | journal=Am J Pathol | year= 1999 | volume= 155 | issue= 6 | pages= 1823-9 | pmid=10595911 | doi=10.1016/S0002-9440(10)65500-9 | pmc=1866939 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10595911  }} </ref>
*Findings on [diagnostic study name] include [finding 1], [finding 2],
and [finding 3].
== Treatment ==
== Treatment ==
* Endodermal sinus tumor is treated with [[surgery]] depending on the [[tumor]] [[marker]] and [[imaging]] as well as [[fertility]] desired.<ref>"NCCN Clinical Practice Guidelines in Oncology: Endodermal sinus tumor. National comprehensive cancer network, 2017; https://www.nccn.org/patients/guidelines/content/PDF/ovarian.pdf."</ref>
* For positive [[tumor]] [[Marker|markers]] and [[imaging]], [[fertility]] desired
**Treat with [[fertility]]-sapring [[surgery]] and comprehensive [[Staging (pathology)|staging]].
* For [[positive]] [[tumor markers]] and [[imaging]], [[fertility]] not desired
**Treat with completion [[Staging (pathology)|staging]] [[surgery]] with possible [[tumor]] reductive [[surgery]] or [[chemotherapy]]
* For negative [[imaging]] and positive or negative [[tumor markers]]
**Treat with [[chemotherapy]]
=== Medical Therapy ===
=== Medical Therapy ===
*There is no treatment for [disease name]; the mainstay of therapy is
* The [[medical]] [[therapy]] for endodermal sinus tumor is [[chemotherapy]] such as [[bleomycin]], [[etoposide]], and [[cisplatin]] for 3 to 4 cycles for 21 days depending on the stage.<ref name="pmid7512129">{{cite journal| author=Williams S, Blessing JA, Liao SY, Ball H, Hanjani P| title=Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. | journal=J Clin Oncol | year= 1994 | volume= 12 | issue= 4 | pages= 701-6 | pmid=7512129 | doi=10.1200/JCO.1994.12.4.701 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7512129  }} </ref><ref>"NCCN Clinical Practice Guidelines in Oncology: Endodermal sinus tumor. National comprehensive cancer network, 2017; https://www.nccn.org/patients/guidelines/content/PDF/ovarian.pdf."</ref>.
supportive care.
===Surgery===
*The mainstay of therapy for [disease name] is [medical therapy 1] and
*[[Surgery]] is the mode of treatment for endodermal sinus tumor with [[adjuvant]] [[chemotherapy]]:<ref name="xxx">Stage I Ovarian Germ Cell Tumors
[medical therapy 2].
. http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_33. URL Accessed on Nov 5, 2015</ref><ref name="abc">Stage II Ovarian Germ Cell Tumors
*[Medical therapy 1] acts by [mechanism of action1].
. http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_43. URL Accessed on Nov 5, 2015</ref><ref name="aaa">Stage III Ovarian Germ Cell Tumors
*Response to [medical therapy 1] can be monitored with [test/physical
. http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_54. URL Accessed on Nov 5, 2015</ref><ref name="ccc">Stage IV Ovarian Germ Cell Tumors
finding/imaging] every [frequency/duration].
. http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_65. URL Accessed on Nov 5, 2015</ref>
=== Surgery ===
===Stage I endodermal sinus tumor===
*Surgery is the mainstay of therapy for [disease name].
 
*[Surgical procedure] in conjunction with [chemotherapy/radiation] is
:* Unilateral [[Salpingo-oophorectomy|salpingo-oophorectom]]<nowiki/>y with [[Adjuvant|adjuvan]]<nowiki/>t [[chemotherapy]]<ref name="urlOvarian Germ Cell Tumors Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK66014/ |title=Ovarian Germ Cell Tumors Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf |format= |work= |accessdate=}}</ref>
the most common approach to the treatment of [disease name].
:* Unilateral [[salpingo-oophorectomy]] followed by [[observation]]
*[Surgical procedure] can only be performed for patients with [disease
 
stage] [disease name].
===Stage II endodermal sinus tumor===
=== Prevention ===
 
*There are no primary preventive measures available for [disease
:* Unilateral [[salpingo-oophorectomy]] with [[adjuvant chemotherapy]]
name].
:* Second-look [[laparotomy]]
*Effective measures for the primary prevention of [disease name]
 
include [measure1], [measure2], and [measure3].
===Stage III endodermal sinus tumor===
*Once diagnosed and successfully treated, patients with [disease name]
 
are followedup
:* Total [[abdominal]] [[hysterectomy]] and bilateral [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]], with or without neoadjuvant [[chemotherapy]]
every [duration]. Followup
:* Unilateral [[salpingo-oophorectomy]] with [[adjuvant chemotherapy]], with or without [[neoadjuvant chemotherapy]]
testing includes [test 1],
:* Second-look [[laparotomy]]
[test 2], and [test 3].
 
===Stage IV endodermal sinus tumor===
 
:* Total [[abdominal]] [[hysterectomy]] and [[Salpingo-oophorectomy|bilateral salpingo-oophorectomy]] with [[adjuvant chemotherapy]] with or without [[neoadjuvant chemotherapy]]
:* Unilateral [[salpingo-oophorectomy]] with [[adjuvant chemotherapy]] with or without [[neoadjuvant chemotherapy]]
 
===Prevention===
* There are no primary preventive measures available for endodermal sinus tumor.
===Video===
{{#ev:youtube|KGKRaTciMK4}}
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 163: Line 146:
[[Category:Proctology]]
[[Category:Proctology]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gynecology]]

Latest revision as of 15:55, 14 November 2019

WikiDoc Resources for Endodermal sinus tumor

Articles

Most recent articles on Endodermal sinus tumor

Most cited articles on Endodermal sinus tumor

Review articles on Endodermal sinus tumor

Articles on Endodermal sinus tumor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Endodermal sinus tumor

Images of Endodermal sinus tumor

Photos of Endodermal sinus tumor

Podcasts & MP3s on Endodermal sinus tumor

Videos on Endodermal sinus tumor

Evidence Based Medicine

Cochrane Collaboration on Endodermal sinus tumor

Bandolier on Endodermal sinus tumor

TRIP on Endodermal sinus tumor

Clinical Trials

Ongoing Trials on Endodermal sinus tumor at Clinical Trials.gov

Trial results on Endodermal sinus tumor

Clinical Trials on Endodermal sinus tumor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Endodermal sinus tumor

NICE Guidance on Endodermal sinus tumor

NHS PRODIGY Guidance

FDA on Endodermal sinus tumor

CDC on Endodermal sinus tumor

Books

Books on Endodermal sinus tumor

News

Endodermal sinus tumor in the news

Be alerted to news on Endodermal sinus tumor

News trends on Endodermal sinus tumor

Commentary

Blogs on Endodermal sinus tumor

Definitions

Definitions of Endodermal sinus tumor

Patient Resources / Community

Patient resources on Endodermal sinus tumor

Discussion groups on Endodermal sinus tumor

Patient Handouts on Endodermal sinus tumor

Directions to Hospitals Treating Endodermal sinus tumor

Risk calculators and risk factors for Endodermal sinus tumor

Healthcare Provider Resources

Symptoms of Endodermal sinus tumor

Causes & Risk Factors for Endodermal sinus tumor

Diagnostic studies for Endodermal sinus tumor

Treatment of Endodermal sinus tumor

Continuing Medical Education (CME)

CME Programs on Endodermal sinus tumor

International

Endodermal sinus tumor en Espanol

Endodermal sinus tumor en Francais

Business

Endodermal sinus tumor in the Marketplace

Patents on Endodermal sinus tumor

Experimental / Informatics

List of terms related to Endodermal sinus tumor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]; Monalisa Dmello, M.B,B.S., M.D. [3]; Shivali Marketkar, M.B.B.S. [4]; Ammu Susheela, M.D. [5]

For patient information, click here Synonyms and keywords: Endodermal sinus tumor(EST), yolk sac tumor.

Overview

Endodermal sinus tumor was first discovered by Dr. Gunner Telium, a Danish pathologist, in 1959. The hypermethylation of the RUNX3 gene promoter and overexpression of GATA-4, a transcription factor has been associated with the development of endodermal sinus tumor. Endodermal sinus tumor is a rare type of malignant ovarian tumor that occurs in the second decade of life. On gross pathology, a solid gray-white with gelatinous, myxoid, or mucoid appearance, necrosis, cystic changes, and hemorrhage are characteristic findings of endodermal sinus tumor. On microscopic histopathological analysis, Schiller-Duval bodies is a characteristic finding of endodermal sinus tumor. Endodermal sinus tumor must be differentiated from other diseases that cause pelvic mass, such as Stein-Leventhal syndrome, and seminoma. In 2015, the incidence of endodermal sinus tumor is estimated to less than 1/100,000 case per year in U.S. Endodermal sinus tumor may be classified according to histology groups.The diagnosis of endodermal sinus tumor is made based on the imaging (U/S and MRI) and alpha fetoprotein (AFP) tumor marker greater than 100 ng/ml. Endodermal sinus tumor have a bimodal distribution more commonly observed among young and adult population. The symptoms of endodermal sinus tumor include the followings: abdominal distention, acute/sub acute abdominal pain. Endodermal sinus tumor is treated with surgery depending on the tumor marker and imaging as well as fertility desired.The medical therapy for endodermal sinus tumor is chemotherapy such as bleomycin, etoposide, and cisplatin for 3 to 4 cycles for 21 days.

Historical Perspective

  • Endodermal sinus tumor was first discovered by Dr. Gunner Telium, a Danish pathologist in 1959.[1][2]

Classification

  • Endodermal sinus tumor may be classified according to histology into 10 groups:[3]

Pathophysiology

  • The hypermethylation of the RUNX3 gene promoter and overexpression of GATA-4, a transcription factor has been associated with the development of endodermal sinus tumor.[4]
  • Ovarian endodermal sinus tumor may be result of differentiation of primitive malignant germ cell components of vitelline structures.[5]
  • On gross pathology, encaptulated, firm, smooth, round, globular, solid gray-white with a gelatinous, myxoid, or mucoid appearance, necrosis, cystic changes, and hemorrhage are characteristic findings of endodermal sinus tumor.[6]
  • On microscopic histopathological analysis, Schiller-Duval bodies (invaginated papillary structures with central vessel) is a characteristic finding of endodermal sinus tumor. The tumors are composed of irregular space lined by flattened to cuboidal cells and recticular stroma[7].[8]

Causes

  • There are no established causes for endodermal sinus tumor.[9]

Differentiating Endodermal sinus tumor from Other Diseases

Endodermal sinus tumor must be differentiated from other diseases that cause pelvic mass, abdominal pain and abdominal distention such as:[10][11]

Epidemiology and Demographics

  • In 2015, the incidence of endodermal sinus tumor is estimated to less than 1/100,000 case per year in U.S.[12]

Age

Gender

  • Endodermal sinus tumor affects men and women equally.[14]

Race

  • There is no racial predilection for endodermal sinus tumor.

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Stage I endodermal sinus tumor

Stage II endodermal sinus tumor

Stage III endodermal sinus tumor

Stage IV endodermal sinus tumor

Prevention

  • There are no primary preventive measures available for endodermal sinus tumor.

Video

{{#ev:youtube|KGKRaTciMK4}}

References

  1. ↑ Carmen, Marcela (2015). Uncommon gynecologic cancers. Chichester, England: Wiley Blackwell. ISBN 978-1-118-65535-1.
  2. ↑ 2.0 2.1 Shah JP, Kumar S, Bryant CS, Ali-Fehmi R, Malone JM, Deppe G; et al. (2008). "A population-based analysis of 788 cases of yolk sac tumors: A comparison of males and females". Int J Cancer. 123 (11): 2671–5. doi:10.1002/ijc.23792. PMID 18767035.
  3. ↑ Weidner, Noel (2009). Modern surgical pathology. Philadelphia, PA: Saunders/Elsevier. ISBN 978-1-4160-3966-2.
  4. ↑ 4.0 4.1 Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T (2003). "Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants". Am J Pathol. 163 (2): 387–91. doi:10.1016/S0002-9440(10)63668-1. PMC 1868235. PMID 12875960.
  5. ↑ Crum, Christopher (2018). Diagnostic gynecologic and obstetric pathology. Philadelphia, PA: Elsevier, Inc. ISBN 978-0-323-44732-4.
  6. ↑ Carmen, Marcela (2015). Uncommon gynecologic cancers. Chichester, England: Wiley Blackwell. ISBN 978-1-118-65535-1.
  7. ↑ Carmen, Marcela (2015). Uncommon gynecologic cancers. Chichester, England: Wiley Blackwell. ISBN 978-1-118-65535-1.
  8. ↑ Kurman RJ, Norris HJ (1976). "Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases". Cancer. 38 (6): 2404–19. doi:10.1002/1097-0142(197612)38:6<2404::aid-cncr2820380629>3.0.co;2-3. PMID 63318.
  9. ↑ Makris, Georgios-Marios (2017). "Giving Birth After Fertility Sparing Treatment for a Yolk Sac Tumour: Case Report". JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. doi:10.7860/JCDR/2017/25820.10524. ISSN 2249-782X.
  10. ↑ Shaaban AM, Rezvani M, Elsayes KM, et al. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. Radiographics. 2014;34(3):777-801.http://pubs.rsna.org/doi/pdf/10.1148/rg.343130067
  11. ↑ Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics. 2002;22(6):1305-25.http://www.ncbi.nlm.nih.gov/pubmed/12432104
  12. ↑ Young JL, Miller RW (1975). "Incidence of malignant tumors in U. S. children". J Pediatr. 86 (2): 254–8. doi:10.1016/s0022-3476(75)80484-7. PMID 1111694.
  13. ↑ Coppes MJ, Rackley R, Kay R (1994). "Primary testicular and paratesticular tumors of childhood". Med Pediatr Oncol. 22 (5): 329–40. PMID 8127257.
  14. ↑ "Endodermal Sinus Tumor - St. Jude Children's Research Hospital".
  15. ↑ 15.0 15.1 Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST (2002). "CT and MR imaging of ovarian tumors with emphasis on differential diagnosis". Radiographics. 22 (6): 1305–25. doi:10.1148/rg.226025033. PMID 12432104.
  16. ↑ 16.0 16.1 16.2 Hung JH, Shen SH, Hung J, Lai CR (2007). "Ultrasound and magnetic resonance images of endodermal sinus tumor". J Chin Med Assoc. 70 (11): 514–8. doi:10.1016/S1726-4901(08)70052-2. PMID 18063508.
  17. ↑ 17.0 17.1 17.2 "Definition of endodermal sinus tumor - NCI Dictionary of Cancer Terms - National Cancer Institute".
  18. ↑ Saia, Philip (2018). Clinical gynecologic oncology. Philadelphia, PA: Elsevier. ISBN 978-0-323-40067-1.
  19. ↑ 19.0 19.1 19.2 Talerman A, Haije WG, Baggerman L (1980). "Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP". Cancer. 46 (2): 380–5. doi:10.1002/1097-0142(19800715)46:2<380::aid-cncr2820460228>3.0.co;2-u. PMID 6155988.
  20. ↑ Saia, Philip (2018). Clinical gynecologic oncology. Philadelphia, PA: Elsevier. ISBN 978-0-323-40067-1.
  21. ↑ Chen, Li Hsun; Yip, Kui-Chuen; Wu, Hsing-Ju; Yong, Su-Boon (2019). "Yolk Sac Tumor in an Eight-Year-Old Girl: A Case Report and Literature Review". Frontiers in Pediatrics. 7. doi:10.3389/fped.2019.00169. ISSN 2296-2360.
  22. ↑ Weidner, Noel (2009). Modern surgical pathology. Philadelphia, PA: Saunders/Elsevier. ISBN 978-1-4160-3966-2.
  23. ↑ Hoffman, Barbara (2012). Williams gynecology. New York: McGraw-Hill Medical. ISBN 9780071716727.
  24. ↑ Gershenson DM, Del Junco G, Herson J, Rutledge FN (1983). "Endodermal sinus tumor of the ovary: the M. D. Anderson experience". Obstet Gynecol. 61 (2): 194–202. PMID 6185892.
  25. ↑ 25.0 25.1 Hoffman, Barbara (2012). Williams gynecology. New York: McGraw-Hill Medical. ISBN 9780071716727.
  26. ↑ Crum, Christopher (2018). Diagnostic gynecologic and obstetric pathology. Philadelphia, PA: Elsevier, Inc. ISBN 978-0-323-44732-4.
  27. ↑ Siltanen S, Anttonen M, Heikkilä P, Narita N, Laitinen M, Ritvos O; et al. (1999). "Transcription factor GATA-4 is expressed in pediatric yolk sac tumors". Am J Pathol. 155 (6): 1823–9. doi:10.1016/S0002-9440(10)65500-9. PMC 1866939. PMID 10595911.
  28. ↑ "NCCN Clinical Practice Guidelines in Oncology: Endodermal sinus tumor. National comprehensive cancer network, 2017; https://www.nccn.org/patients/guidelines/content/PDF/ovarian.pdf."
  29. ↑ Williams S, Blessing JA, Liao SY, Ball H, Hanjani P (1994). "Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group". J Clin Oncol. 12 (4): 701–6. doi:10.1200/JCO.1994.12.4.701. PMID 7512129.
  30. ↑ "NCCN Clinical Practice Guidelines in Oncology: Endodermal sinus tumor. National comprehensive cancer network, 2017; https://www.nccn.org/patients/guidelines/content/PDF/ovarian.pdf."
  31. ↑ Stage I Ovarian Germ Cell Tumors . http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_33. URL Accessed on Nov 5, 2015
  32. ↑ Stage III Ovarian Germ Cell Tumors . http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_54. URL Accessed on Nov 5, 2015
  33. ↑ Stage IV Ovarian Germ Cell Tumors . http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_65. URL Accessed on Nov 5, 2015
  34. ↑ "Ovarian Germ Cell Tumors Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf".
Retrieved from "https://www.wikidoc.org/index.php?title=Endodermal_sinus_tumor&oldid=1589185"